KLK6 and ovarian neoplasm: In order to characterise the expression pattern of hK6 in different subtypes and stages of ovarian tumour tissues and to develop a tool for the potential use of measuring hK6 levels in patient serum, we have established a novel monoclonal antibody that has high specificity and reactivity to hK6.